Bronchiolitis in COVID-19 times: a nearly absent disease?

Eur J Pediatr. 2021 Jun;180(6):1969-1973. doi: 10.1007/s00431-021-03968-6. Epub 2021 Jan 30.

Abstract

Stay-at-home orders, physical distancing, face masks and other non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. Bronchiolitis is a clinically diagnosed viral infection of the lower respiratory tract, and causes a yearly seasonal wave of admissions in paediatric wards worldwide. We counted 92,5% less bronchiolitis hospitalisations in Antwerp before the expected end of the peak this year (of which only 1 RSV positive), as compared to the last 3 years. Furthermore, there was a >99% reduction in the number of registered RSV cases in Belgium.Conslusion: The 2020 winter bronchiolitis peak is hitherto nonexistent, but we fear a 'delayed' spring/summer bronchiolitis peak when most NPIs will be relaxed and pre-pandemic life restarts. What is known? • Bronchiolitis causes a yearly seasonal wave of admissions in paediatric departments worldwide. • Non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. What is new? • The 2020 winter bronchiolitis peak is hitherto nonexistent. • A 'delayed' spring or summer bronchiolitis peak could happen when most NPIs will be relaxed and pre-pandemic life restarts.

Keywords: Bronchiolitis; COVID-19; Lockdown; Non-pharmaceutical interventions (NPIs); Paediatric Infections; RSV.

MeSH terms

  • Belgium
  • Bronchiolitis* / epidemiology
  • Bronchiolitis* / therapy
  • COVID-19*
  • Child
  • Humans
  • Pandemics
  • Respiratory Syncytial Virus Infections* / diagnosis
  • Respiratory Syncytial Virus Infections* / epidemiology
  • SARS-CoV-2